Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 29 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Yavropoulou, Maria P  [Clear All Filters]
Journal Article
Yavropoulou, M. P., Vaios V., Pikilidou M., Chryssogonidis I., Sachinidou M., Tournis S., et al. (2017).  Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis.. J Clin Densitom. 20(4), 490-497.
Yavropoulou, M. P., Kolynou A., Makras P., Pikilidou M., Nanoudis S., Skoura L., et al. (2021).  Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss.. Biomedicines. 9(4), 
Anastasilakis, A. D., Polyzos S. A., Makras P., Rauner M., Sonnleitner L., Hawa G., et al. (2019).  Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.. J Musculoskelet Neuronal Interact. 19(3), 253-257.
Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., Ntenti C., Mandanas S., & Makras P. (2021).  Circulating sclerostin levels during denosumab discontinuation and the subsequent early or late zoledronate infusion.. Endocrine.
Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., & Makras P. (2020).  Combination and sequential treatment in women with postmenopausal osteoporosis.. Expert Opin Pharmacother. 21(4), 477-490.
Anastasilakis, A. D., Polyzos S. A., Yavropoulou M. P., Appelman-Dijkstra N. M., Ntenti C., Mandanas S., et al. (2021).  Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation.. Calcif Tissue Int.
Yavropoulou, M. P., Poulios C., Foroulis C., Tournis S., Hytiroglou P., Kotsa K., et al. (2018).  Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor.. Endocrinol Diabetes Metab Case Rep. 2018,
Makras, P., Appelman-Dijkstra N. M., Papapoulos S. E., van Wissen S., Winter E. M., Polyzos S. A., et al. (2021).  The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation.. J Clin Endocrinol Metab.
Yavropoulou, M. P., Kotsa K., Anastasiou O., O'Dorisio T. M., Pappas T. N., & Yovos J. G. (2009).  Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs.. Neurosci Lett. 460(2), 148-51.
Yavropoulou, M. P., Kotsa K., Kesisoglou I., Gotzamani-Psarakou A., & Yovos J. G. (2010).  Effect of intracerebroventricular infusion of neurotensin in glucose-dependent insulinotropic peptide secretion in dogs.. Peptides. 31(1), 150-4.
Anastasilakis, A. D., Papachatzopoulos S., Makras P., Gkiomisi A., Nikolakopoulos P., Polyzos S. A., et al. (2022).  The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis.. Bone. 158, 116354.
Pitetzis, D. A., Spilioti M. G., Yovos J. G., & Yavropoulou M. P. (2017).  The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.. Seizure. 48, 36-43.
Anastasilakis, A. D., Polyzos S. A., Makras P., Trovas G., Yavropoulou M. P., & Tournis S. (2021).  Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation.. J Clin Densitom.
Yavropoulou, M. P., Maladaki A., Topouridou K., Kotoula V., Poulios C., Daskalaki E., et al. (2016).  Expression pattern of the Hedgehog signaling pathway in pituitary adenomas.. Neurosci Lett. 611, 94-100.
Tournis, S., Yavropoulou M. P., Polyzos S. A., & Doulgeraki A. (2021).  Hypophosphatasia.. J Clin Med. 10(23), 
Pontikis, C., Yavropoulou M. P., Toulis K. A., Kotsa K., Kazakos K., Papazisi A., et al. (2011).  The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study.. J Womens Health (Larchmt). 20(6), 971-6.
Yavropoulou, M. P., Pikilidou M., Pantelidou D., Tsalikakis D. G., Mousiolis A., Chalkia P., et al. (2017).  Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell Disease.. Hemoglobin. 41(1), 6-11.
Anastasilakis, A. D., Polyzos S. A., Vorkas P. A., Gkiomisi A., Yavropoulou M. P., Rauner M., et al. (2023).  Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study.. J Clin Med. 12(16), 
Anastasilakis, A. D., Tournis S., Yavropoulou M. P., Polyzos S. A., & Makras P. (2018).  Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?. Calcif Tissue Int. 103(1), 107-108.
Maladaki, A., Yavropoulou M. P., Kotsa K., Tranga T., Ventis S., & Yovos J. G. (2012).  Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6.. Hormones (Athens). 11(1), 104-8.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z. A., Yavropoulou M. P., & Makras P. (2021).  Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations.. Maturitas. 147, 19-25.
Karatzoglou, I., Yavropoulou M. P., Pikilidou M., Germanidis G., Akriviadis E., Papazisi A., et al. (2014).  Postprandial response of bone turnover markers in patients with Crohn's disease.. World J Gastroenterol. 20(28), 9534-40.
Makras, P., Yavropoulou M. P., Polyzos S. A., Papapoulos S. E., Georgakopoulou D., Papatheodorou A., et al. (2023).  The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.. Osteoporos Int.
Mediskou, P., Yavropoulou M. P., Kotsa K., Tsekmekidou X., Psarakou-Gotzamani A., Papazisi A., et al. (2011).  The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.. Clin Endocrinol (Oxf). 74(3), 306-11.
Yavropoulou, M. P., Poulios C., Michalopoulos N., Gatzou A., Chrisafi S., Mantalovas S., et al. (2018).  A Role for Circular Non-Coding RNAs in the Pathogenesis of Sporadic Parathyroid Adenomas and the Impact of Gender-Specific Epigenetic Regulation.. Cells. 8(1), 

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.